48.40000 EUR
4.2
9.50%
Last update Dec 16, 8:14 AM CET
Main market
Day range
48.40000
48.40000
Previous close
44.20000
Open
48.40000
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
48.40
4.20
9.50%

Analysis

Revenue estimate Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Dec 2025)
Next year
(Dec 2026)
Number of Analysts 8 5 8 8
Avg. estimate 10.44M 10.10M 43.85M 42.13M
Low estimate 6.90M 6M 40M 24M
High estimate 15.81M 12.50M 49.24M 54.44M
Last year sales 29.18M 10.46M 98.43M 43.85M
Sales growth -0.64 -0.03 -0.55 -0.04
Access /revenue_estimate data via our API — starting from the Ultra plan.
EPS revisions Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Dec 2025)
Next year
(Dec 2026)
Up last 7 days 0 0 0 0
Up last 30 days 0 0 0 0
Down last 7 days 0 0 0 0
Down last 30 days 0 0 0 0
Access /eps_revisions data via our API — starting from the Ultra plan.

Analyst ratings

Firm Date Action
Citigroup Nov 26, 2025 Initiates
Jefferies Nov 26, 2025 Maintains
B. Riley Securities Sep 23, 2025 Maintains
BTIG Sep 19, 2025 Reiterates
B. Riley Securities Jul 08, 2025 Maintains
HC Wainwright & Co. Jun 24, 2025 Maintains
Access /analyst_ratings/light data via our API — starting from the Ultra plan.
Main market

Exchange is currently active.
Closing in 3 hours 53 minutes

18:06
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).